Amgen Inc. (AMGN) Q2 2010 Earnings Results

Amgen Beats on EPS, Stock Down 0.73%

Amgen's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 0.73%. The lack of revenue figures and guidance may have contributed to investor caution.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.38	N/A	+7.39%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Neutral

Management expressed confidence in their current product offerings but did not provide specific guidance for the upcoming quarters. They focused on long-term growth strategies.

Management highlighted the strength of their product pipeline.

They emphasized ongoing investments in research and development.

No specific guidance was provided for future quarters.

Amgen Beats on EPS, Stock Down 0.73%

Key numbers

Management commentary

Amgen Inc.

More earnings this week

Amgen Beats on EPS, Stock Down 0.73%

Key numbers

Management commentary